Johnson & Johnson will develop and deliver 100 million doses of its experimental coronavirus vaccine for the US in a deal that totals over $1 billion. The deal also gives the US the option to order an additional 200 million doses. The doses will be provided to Americans for free if they're used in a COVID-19 vaccination campaign.